Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE-PLP: Losartan vs Perindopril in Black Type 2 Diabetics
NCT04222686Phase 4Completed
- Sponsor
- Yaoundé Central Hospital
- Start
- Dec 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of losartan, perindopril in type 2 diabetes mellitus (T2DM), hypertension (HTN), albuminuria, sponsored by Yaoundé Central Hospital. Started Dec 2017; status: completed.
02
Drugs
losartanperindopril
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)albuminuria
Beyond the preview
Go deeper on NCT04222686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04222686.